Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood

Pituitary

Volumn 10, Issue 2, 2007, Pages 141-149

  Corneli, Ginevra ^a   Gasco, Valentina ^b   Prodam, Flavia ^a   Grottoli, Silvia ^b   Aimaretti, Gianluca ^a   Ghigo, Ezio ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

GHRH; Growth hormone deficiency; ITT

Indexed keywords

ARGININE; GONADORELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE SECRETAGOGUE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY MASS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FALSE POSITIVE RESULT; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPITUITARISM; INSULIN TOLERANCE TEST; NORMAL VALUE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; REFERENCE VALUE; RELIABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ARGININE; BODY WEIGHT; DIAGNOSTIC TECHNIQUES, ENDOCRINE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; PRACTICE GUIDELINES AS TOPIC;

EID: 34249913955     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0031-0     Document Type: Article

References (91)

1. Growth Hormone Research Society (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. J Clin Endocrinol Metab 83:379-381
2. Arafah BM, Nasrallah MP (2001) Pituitary tumors: Pathophysiology, clinical manifestations and management. Endocr Relat Cancer 8:287-305
3. Corneli G, Baldelli R, Di Somma C, Rovere S, Gaia D, Pellegrino M, Gasco V, Durante C, Grottoli S, Colao A, Tamburrano G, Lombardi G, Ghigo E, Aimaretti G (2003) Occurrence of GH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses. Growth Horm IGF Res 13:104-108
4. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M; European Society of Paediatric Endocrinology (2005) Consensus statement on the management of the GH-treated adolescent in the transition to adult care (Review). Eur J Endocrinol 152(2):165-170
5. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, Stephens PA; Endocrine Society's Clinical Guidelines Subcommittee (2006) Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:1621-1634
6. Thorner MO, Vance ML, Laws Jr ER, Horvath E, Kovacs K (1998) The anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P (eds) Williams Textbook of Endocrinology, 9th edn. W.B. Saunders Company, Philadelphia, p 165
7. Agha A, Rogers B, Sherlock M, O'Kelly P, Tormey W, Phillips J, Thompson CJ (2004) Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab 89(10):4929-4936
8. Kreitschmann-Andermahr I, Hoff C, Saller B, Niggemeier S, Pruemper S, Hutter BO, Rohde V, Gressner A, Matern S, Gilsbach JM (2004) Prevalence of pituitary deficiency in patients after aneurysmal subarachnoid hemorrhage. J Clin Endocrinol Metab 89:4986-4992
9. Aimaretti G, Ambrosio MR, Di Somma C, Gasperi M, Cannavo S, Scaroni C, Fusco A, Del Monte P, De Menis E, Faustini-Fustini M, Grimaldi F, Logoluso F, Razzore P, Rovere S, Benvenga S, Degli Uberti EC, De Marinis L, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E (2005) Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study. J Clin Endocrinol Metab 90(11):6085-6092
10. Masel BE (2005) Traumatic brain injury induced hypopituitarism: The need and hope of rehabilitation. Pituitary 8(3-4):263-266
11. Ghigo E, Masel B, Aimaretti G, Leon-Carrion J, Casanueva FF, Dominguez-Morales MR, Elovic E, Perrone K, Stalla G, Thompson C, Urban R (2005) Consensus guidelines on screening for hypopituitarism following traumatic brain injury (Review). Brain Inj 19(9):711-724
12. Ghigo E, Masel B, Aimaretti G, et al (2005) Consensus guidelines on screening for hypopituitarism following traumatic brain injury. On behalf of Participants in the Hypopituitarism Following Traumatic Brain Injury Consensus Workshop. Brain Injury 19(9):711-724
13. Casanueva FF, Ghigo E, Popovic V; Athens TBI; Hypopituitarism Study Group (2005) Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue. J Endocrinol Invest 28(3):299
14. Giordano G, Aimaretti G, Ghigo E (2005) Variations of pituitary function over time after brain injuries: The lesson from a prospective study. Pituitary 8(3-4):227-231
15. Bondanelli M, Ambrosio MR, Zatelli MC, De Marinis L, degli Uberti EC (2005) Hypopituitarism after traumatic brain injury (Review). Eur J Endocrinol 152(5):679-691
16. Popovic V, Aimaretti G, Casanueva FF, Ghigo E (2005) Hypopituitarism following traumatic brain injury (Review). Growth Horm IGF Res 15(3):177-184
17. Urban RJ (2006) Hypopituitarism after acute brain injury (Review). Growth Horm IGF Res 16(Suppl. A):S25-S29
18. Schneider HJ, Rovere S, Corneli G, Croce CG, Gasco V, Ruda R, Grottoli S, Stalla GK, Soffietti R, Ghigo E, Aimaretti G (2006) Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors. Eur J Endocrinol 155:559-566
19. Agha A, Thompson CJ (2006) Anterior pituitary dysfunction following traumatic brain injury (TBI) (Review). Clin Endocrinol 64(5):481-488
20. Jones J, Clemmons DR (1995) Insulin-like growth factor and their binding proteins: Biological actions. Endocr Rev 16:3
21. Granada ML, Murillo J, Lucas A, Salinas I, Llopis MA, Castells I, Foz M, Sanmarti A (2000) Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: Importance of an appropriate reference population. Eur J Endocrinol 142(3):243-253
22. Ghigo E, Aimaretti G, Arvat E, Camanni F (2001) Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 15:29-38
23. Camanni F (2006) Diagnosis of adult growth hormone deficiency: Still a matter of debate (Review). J Endocrinol Invest 29(2):190-194
24. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Bellone J, Camanni F, Ghigo E (1998). Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults. J Endocrinol Invest 21:506-511
25. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG (2001) Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 86:3001-3008
26. Aimaretti G, Corneli G, Baldelli R, Di Somma C, Gasco V, Durante C, Ausiello L, Rovere S, Grottoli S, Tamburrano G, Ghigo E (2003) Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clin Endocrinol 59:56-61
27. Aimaretti G, Corneli G, Rovere S, Granata R, Baldelli R, Grottoli S, Ghigo E (2004) Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency (Review). Horm Res 62:26-33
28. Aimaretti G, Baldelli R, Corneli G, Croce C, Rovere S, Baffoni C, Bellone S, Gasco S, Granata R, Grottoli S, Ghigo E (2005) IGFs and IGFBPs in adult growth hormone deficiency (Review). Endocr Dev 9:76-88
29. Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Durante C, Migliaretti G, Colao A, Tamburrano C, Lombardi G, Ghigo E, Camanni I (2005). Different degrees of GH deficiency evidenced by GHRH-arginine test and IGF-I levels in adults with pituitary disease. J Endocrinol Invest 28:247-252
30. Cianfarani S, Liguori A, Boemi S, Maghnie M, Iughetti L, Wasniewska M, Street ME, Zucchini S, Aimaretti G, Germani D (2005) Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: Association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment. J Clin Endocrinol Metab 90(11):6028-6034
31. Ross RJ (2000) GH, IGF-I and binding proteins in altered nutritional states (Review). Int J Obes Relat Metab Disord 24:S92-S95
32. Iglesias P, Bayon C, Mendez J, Gancedo PG, Grande C, Diez JJ (2001) Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction. Thyroid 11:1043-1048
33. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, Hypos CCS Advisory Board, U.S. HypoCCS Study Group (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:477-485
34. Abs R (2003) Update on the diagnosis of GH deficiency in adults. Eur J Endocrinol 148:S3-S8
35. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, Rodbard HW, Seibel JA, Vance ML, Zimmerman D, Palumbo PJ, Bergman DA, Garber JR, Hamilton CR Jr, Petak SM, Rettinger HI, Service FJ, Shanker TP, Stoffer SS, Tourletot JB (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr Pract 9:64-76
36. National Institute for Clinical Excellence (2006) Human growth hormone (somatropin) in adults with growth hormone deficiency. Technology Appraisal 64
37. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E (1998) Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618
38. Casanueva FF, Dieguez C (1999) Growth hormone secretagogues: physiological role and clinical utility. Trends Endocrinol Metab 10(1):30-38
39. Popovic V, Leal A, Micic D, Koppeschaar HP, Torres E, Paramo C, Obradovic S, Dieguez C, Casanueva FF (2000) GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 356(9236):1137-1142
40. Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, Arvat E, Camanni F, Ghigo E (2000) Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 142:347-352
41. Baldelli R, Otero XL, Camina JP, Gualillo O, Popovic V, Dieguez C, Casanueva FF (2001) Growth hormone secretagogues as diagnostic tools in disease states (Review). Endocrine 14(1):95-99
42. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067-2079
43. Aimaretti G, Baldelli R, Corneli G, Bellone S, Rovere S, Croce C, Ragazzoni F, Giordano R, Arvat E, Bona G, Ghigo E (2004) GHRH and GH secretagogues: Clinical perspectives and safety (Review). Pediatr Endocrinol Rev 2:86-92
44. Popovic V, Pekic S, Doknic M, Micic D, Damjanovic S, Zarkovic M, Aimaretti G, Corneli G, Ghigo E, Deiguez C, Casanueva FF (2003) The effectiveness of arginine + GHRH test compared with GHRH + GHRP-6 test in diagnosing growth hormone deficiency in adults. Clin Endocrinol 59(2):251-257
45. Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Durante C, Migliaretti G, Colao A, Tamburrano C, Lombardi G, Ghigo E, Camanni I (2005) Different degrees of GH deficiency evidenced by GHRH-arginine test and IGF-I levels in adults with pituitary disease. J Endocrinol Invest 28:247-252
46. Broglio F, Prodam F, Riganti F, Muccioli G, Ghigo E (2006) Ghrelin: From somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions (Review). Front Horm Res 35:102-114
47. Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A (1994) An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol 41:123-128
48. Hoeck HC, Vestergoard P, Jakobson PE, Laurberg P (1995) Test of growth hormone secretion in adults: Poor reproducibility of the insulin tolerance test. Eur J Endocrinol 133:305-312
49. Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P (1997) Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 29:106-110
50. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KKY (1994) Diagnosis of growth hormone deficiency in adults. Lancet 343:1064-1068
51. Kopelman PG, Noonan K, Goulton R, Forrest AJ (1985) Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity. Clin Endocrinol 23:87-94
52. Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E, Ghigo E (1997) Maximal secretory capacity of somatotrope cells in obesity: Comparison with GH deficiency. Int J Ob Rel Metab Disord 21:27-32
53. Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G, Ghigo E (1999) Assessment of GH/ IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH-arginine test. J Endocrinol Invest 22:424-429
54. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF, Dieguez C (2003) Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 149:117-122
55. Bonert VS, Elashoff JD, Barnett P, Melmed S (2004) Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: Diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab 89:3397-3401
56. Haijma SV, van Dam PS, de Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP (2005) The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men. Eur J Endocrinol 152:575-580
57. Qu XD, Gaw Gonzalo IT, Al Sayed MJ, Cohan P, Christenson PD, Swerdloff RS, Kelly DF, Wang C (2005) Influence of body mass index and gender or growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab 90:1563-1569
58. Kelestimur F, Popovic V, Leal A, Van Dam PS, Torres E, Perez Mendez LF, Greenman Y, Koppeschaar HP, Dieguez C, Casanueva FF (2006) Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test. Clin Endocrinol 64:667-671
59. Gomez JM, Espadero RM, Escobar-Jiménez F, Hawkins F, Picò A, Herrera-Pombo JL, Vilardell E, Durán A, Mesa J, Faure E, Saumartì A (2002) Growth hormone release after glucagons as a reliable test of growth hormone assessment in adults. Clin Endocrinol 56:329-334
60. Conceicao FL, da Costa e Silva A, Leal Costa AJ, Vaisman M (2003) Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest 26:1065-1070
61. Aimaretti G, Bellone S, Baffoni C, Corneli G, Origlia C, Di Vito L, Rovere S, Arvat E, Camanni F, Ghigo E (2001) Short procedure of GHRH plus arginine test in clinical practice. Pituitary 4(3):129-134
62. Popovic V, Pekic S, Micic D, Damjanovic S, Marikovic J, Simic M, Dieguez C, Casanueva FF (2004) Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adults. Clin Endocrinol 60:185-191
63. Arvat E, Camanni F, Ghigo E (1997) Age-related growth hormone-releasing activity of growth hormone secretagogues in humans (Review). Acta Paediatr Suppl 423:92-96
64. Gottero C, Benso A, Prodam F, Broglio F, Castiglioni C, Bo M, Deghenghi R, Ghigo E, Arvat E (2002) Age-related variations of the GH response to GH secretagogues in humans. J Endocrinol Invest 25:42-43
65. Muller EE, Rigamonti AE, Colonna Vde G, Locatelli V, Berti F, Cella SG (2002) GH-related and extra-endocrine actions of GH secretagogues in aging (Review). Neurobiol Aging 23(5):907-919
66. Merriam GR, Schwartz RS, Vitiello MV (2003) Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine 22:41-48
67. Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E (1999) Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: Comparison with insulin-induced hypoglycemia test. J Clin Endocrinol Metab 84(8):2633-2637
68. Mahajan T, Lightman SL (2000) A simple test for growth hormone deficiency in adults. J Clin Endocrinol Metab 85(4):1473-1476
69. Aimaretti G, Baffoni C, Broglio F, Janssen JA, Corneli G, Deghenghi R, van der Lely AJ, Ghigo E, Arvat E (2002) Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin Endocrinol 56(6):765-771
70. Leal A, Lage M, Popovic V, Torres E, Koppeschaar HP, Paramo C, Micic D, Garcia-Mayor RV, Dieguez C, Casanueva FF (2002) A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin Endocrinol 57(3):377-384
71. Popovic V, Pekic S, Golubicic I, Doknic M, Dieguez C, Casanueva FF (2002) The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6. J Clin Endocrinol Metab 87(5):2095-2099
72. Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. Clin Endocrinol Metab 88(1):95-102
73. Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86(4):1574-1579
74. Maghnie M, Cavigioli F, Tinelli C, Autelli M, Arico M, Aimaretti G, Ghigo E (2002) GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 87(6):2740-2744
75. Ham JN, Ginsberg JP, Hendell CD, Moshang T Jr (2005) Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol 62(5):628-632
76. Bjork J, Link K, Erfurth EM (2005) The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukaemia treated with cranial irradiation. J Clin Endocrinol Metab 90(11):6048-6054
77. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G (2005) The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257-264
78. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF, Dieguez C (1998) Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 83:4350-4354
79. Iranmanesh A, Lizarralde G, Veldhuis JD (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
80. Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, Arvat E, Ghigo E (2000) The GH/IGF-I axis in obesity: Influence of neuro-endocrine and metabolic factors (Review). Int J Obes Relat Metab Disord 24:S96-S99
81. Maccario M, Tassone F, Grottoli S, Rossetto R, Gauna C, Ghigo E (2002). Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity (Review). Ann Endocrinol (Paris) 63(2 Pt 1):140-144
82. Scacchi M, Pincelli AI, Cavagnini F (1999) Growth hormone in obesity. Int J Ob Rel Metab Dis 23:260-271
83. Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C, Thorner MO, Hartman ML (2001) Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 86:3845-3852
84. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF, Dieguez C (1998) Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 83:4350-4354
85. Lanzi R, Luzi L, Caumo A, Andreotti AC, Manzoni MF, Malighetti ME, Sereni LP, Pontiroli AE (1999) Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects. Metabolism 48:1152-1156
86. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G (1991) Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
87. Cook DM, Ludlam WH, Cook MB (2000) The adult growth hormone deficiency syndrome. Adv Intern Med 45:297-315
88. Cuneo RC, Salomon F, McGauley GA, Sonksen PH (1992) The growth hormone deficiency syndrome in adults. Clin Endocrinol 37:387-397
89. De Boer H, Blok G-J, van der Veen E (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
90. Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M, Mazza E, Camanni F (1992) Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism 41:560-563
91. Procopio M, Maccario M, Grottoli S et al (1995) Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Clin Endocrinol 43:665-669